Home RNA RNAi

RNAi

Latest
RNAi

FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis

Illustration of chromosome 16 showing the 14 fly counterparts of the 25 human genes located in a deletion on the chromosome that is associated with autism risk. Researchers used RNA interference (RNAi) to the reduce the expression of these genes individually and in tandem to test how the interactions of these genes modulate neurodevelopmental symptoms associated with the deletion. Interactions between genes that either enhance or suppress the affect of reduced expression are shown by red or blue lines. [Girirajan Laboratory/Penn State]
RNAi

Autism Genetic Complexity Comes to Light

RNAi

Regeneron, Alnylam to Pursue RNAi Treatments for NASH

Source: Pixabay
RNAi

Huntington siRNA Highly Toxic to Cancer Cells

Trim-Away
RNAi

Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins Straightaway

RNAi

Boehringer Ingelheim, Dicerna Launch Liver Disease Collaboration

RNAi

Alnylam, Sanofi RNAi Candidate Patisiran Aces Phase III Trial

RNAi

NEWS: Whole Genome CRISPR Screening Gets Leg Up from Newly Developed...

RNAi

“Fossil” Antiviral System May Furnish Bones of New RNA-Based Therapies

RNAi

MicroRNA Maneuvers Limit Time on Target, Maintain Ace Status

Load more

Recently Featured

Stay Connected

557,187FansLike
46,430FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up